BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32506380)

  • 1. Cyclins, Cyclin-Dependent Kinases, and Cyclin-Dependent Kinase Inhibitors in the Mouse Nervous System.
    Grison A; Atanasoski S
    Mol Neurobiol; 2020 Jul; 57(7):3206-3218. PubMed ID: 32506380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclins and CDKS in development and cancer: lessons from genetically modified mice.
    Santamaria D; Ortega S
    Front Biosci; 2006 Jan; 11():1164-88. PubMed ID: 16146805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdks, cyclins and CKIs: roles beyond cell cycle regulation.
    Lim S; Kaldis P
    Development; 2013 Aug; 140(15):3079-93. PubMed ID: 23861057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
    Coats S; Whyte P; Fero ML; Lacy S; Chung G; Randel E; Firpo E; Roberts JM
    Curr Biol; 1999 Feb; 9(4):163-73. PubMed ID: 10074425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin proteolysis and CDK inhibitors: two redundant pathways to maintain genome stability in mammalian cells.
    Chibazakura T
    Cell Cycle; 2004 Oct; 3(10):1243-5. PubMed ID: 15477761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for coordinated interaction of cyclin D3 with p21 and cdk6 in directing the development of uterine stromal cell decidualization and polyploidy during implantation.
    Tan J; Raja S; Davis MK; Tawfik O; Dey SK; Das SK
    Mech Dev; 2002 Feb; 111(1-2):99-113. PubMed ID: 11804782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions.
    Klein MA
    Adv Protein Chem Struct Biol; 2020; 121():115-141. PubMed ID: 32312419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of rat postnatal lung alveolar development by glucocorticoids: involvement of the p21CIP1 and p27KIP1 cyclin-dependent kinase inhibitors.
    Corroyer S; Schittny JC; Djonov V; Burri PH; Clement A
    Pediatr Res; 2002 Feb; 51(2):169-76. PubMed ID: 11809910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arabidopsis KRPs have distinct inhibitory activity toward cyclin D2-associated kinases, including plant-specific B-type cyclin-dependent kinase.
    Nakai T; Kato K; Shinmyo A; Sekine M
    FEBS Lett; 2006 Jan; 580(1):336-40. PubMed ID: 16376885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential.
    Andrés V
    Cardiovasc Res; 2004 Jul; 63(1):11-21. PubMed ID: 15194457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclins and cdks throughout murine carcinogenesis.
    Yerly-Motta V; Contassot E; Pavy JJ; Tiberghien P; Hervé P
    Cell Mol Biol (Noisy-le-grand); 1999 Dec; 45(8):1217-28. PubMed ID: 10643971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase inhibitors in yeast, animals, and plants: a functional comparison.
    De Clercq A; Inzé D
    Crit Rev Biochem Mol Biol; 2006; 41(5):293-313. PubMed ID: 16911957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta.
    Ravitz MJ; Wenner CE
    Adv Cancer Res; 1997; 71():165-207. PubMed ID: 9111866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle protein suppression and p21 induction in differentiating Caco-2 cells.
    Evers BM; Ko TC; Li J; Thompson EA
    Am J Physiol; 1996 Oct; 271(4 Pt 1):G722-7. PubMed ID: 8897894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
    Roskoski R
    Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Less-well known functions of cyclin/CDK complexes.
    Palmer N; Kaldis P
    Semin Cell Dev Biol; 2020 Nov; 107():54-62. PubMed ID: 32386818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
    Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic insights into avian reovirus p17-modulated suppression of cell cycle CDK-cyclin complexes and enhancement of p53 and cyclin H interaction.
    Chiu HC; Huang WR; Liao TL; Chi PI; Nielsen BL; Liu JH; Liu HJ
    J Biol Chem; 2018 Aug; 293(32):12542-12562. PubMed ID: 29907572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulators of cyclin-dependent kinases and their roles in cancers.
    Lee MH; Yang HY
    Cell Mol Life Sci; 2001 Nov; 58(12-13):1907-22. PubMed ID: 11766887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of cyclin-dependent kinase regulation: structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors.
    Pavletich NP
    J Mol Biol; 1999 Apr; 287(5):821-8. PubMed ID: 10222191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.